Irish journal of medical science
-
Randomized Controlled Trial Clinical Trial
Naltrexone for alcohol-dependent patients.
Clinical trials have shown that naltrexone 50 mg/day reduces alcohol consumption and relapse rates in alcohol dependents. ⋯ The results support the efficacy and safety of naltrexone for outpatient treatment of alcohol-dependent individuals in Iran.